Niva Bupa Health Insurance Company Limited (NSE: NIVABUPA.NS) Stock Competitors & Peer Comparison

Niva Bupa Health Insurance Company Limited (NSE: NIVABUPA.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVABUPA.NS stands at 147.2B. In comparison, LICI.BO has a market cap of 5.2T. Regarding current trading prices, NIVABUPA.NS is priced at ₹79.59 on the NSE, while LICI.BO trades at ₹411.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVABUPA.NS currently has a P/E ratio of 41.20, whereas LICI.BO's P/E ratio is 11.70. In terms of profitability, NIVABUPA.NS's ROE is +0.09%, compared to LICI.BO's ROE of +0.18%. Regarding short-term risk, NIVABUPA.NS is less volatile compared to LICI.BO. This indicates lower risk in terms of short-term price fluctuations for NIVABUPA.NS.Check LICI.BO's competition here

Niva Bupa Health Insurance Company Limited (NSE: NIVABUPA.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVABUPA.NS stands at 147.2B. In comparison, LICI.NS has a market cap of 5.2T. Regarding current trading prices, NIVABUPA.NS is priced at ₹79.59 on the NSE, while LICI.NS trades at ₹407.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVABUPA.NS currently has a P/E ratio of 41.20, whereas LICI.NS's P/E ratio is 6.50. In terms of profitability, NIVABUPA.NS's ROE is +0.09%, compared to LICI.NS's ROE of +0.18%. Regarding short-term risk, NIVABUPA.NS is less volatile compared to LICI.NS. This indicates lower risk in terms of short-term price fluctuations for NIVABUPA.NS.Check LICI.NS's competition here

Niva Bupa Health Insurance Company Limited (NSE: NIVABUPA.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVABUPA.NS stands at 147.2B. In comparison, SBILIFE.BO has a market cap of 1.8T. Regarding current trading prices, NIVABUPA.NS is priced at ₹79.59 on the NSE, while SBILIFE.BO trades at ₹1,769.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVABUPA.NS currently has a P/E ratio of 41.20, whereas SBILIFE.BO's P/E ratio is 68.32. In terms of profitability, NIVABUPA.NS's ROE is +0.09%, compared to SBILIFE.BO's ROE of +0.14%. Regarding short-term risk, NIVABUPA.NS is more volatile compared to SBILIFE.BO. This indicates higher risk in terms of short-term price fluctuations for NIVABUPA.NS.Check SBILIFE.BO's competition here

Niva Bupa Health Insurance Company Limited (NSE: NIVABUPA.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVABUPA.NS stands at 147.2B. In comparison, SBILIFE.NS has a market cap of 1.7T. Regarding current trading prices, NIVABUPA.NS is priced at ₹79.59 on the NSE, while SBILIFE.NS trades at ₹1,731.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVABUPA.NS currently has a P/E ratio of 41.20, whereas SBILIFE.NS's P/E ratio is 66.83. In terms of profitability, NIVABUPA.NS's ROE is +0.09%, compared to SBILIFE.NS's ROE of +0.14%. Regarding short-term risk, NIVABUPA.NS is less volatile compared to SBILIFE.NS. This indicates lower risk in terms of short-term price fluctuations for NIVABUPA.NS.Check SBILIFE.NS's competition here

Niva Bupa Health Insurance Company Limited (NSE: NIVABUPA.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVABUPA.NS stands at 147.2B. In comparison, HDFCLIFE.BO has a market cap of 1.2T. Regarding current trading prices, NIVABUPA.NS is priced at ₹79.59 on the NSE, while HDFCLIFE.BO trades at ₹552.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVABUPA.NS currently has a P/E ratio of 41.20, whereas HDFCLIFE.BO's P/E ratio is 62.18. In terms of profitability, NIVABUPA.NS's ROE is +0.09%, compared to HDFCLIFE.BO's ROE of +0.11%. Regarding short-term risk, NIVABUPA.NS is less volatile compared to HDFCLIFE.BO. This indicates lower risk in terms of short-term price fluctuations for NIVABUPA.NS.Check HDFCLIFE.BO's competition here

Niva Bupa Health Insurance Company Limited (NSE: NIVABUPA.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVABUPA.NS stands at 147.2B. In comparison, HDFCLIFE.NS has a market cap of 1.2T. Regarding current trading prices, NIVABUPA.NS is priced at ₹79.59 on the NSE, while HDFCLIFE.NS trades at ₹550.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVABUPA.NS currently has a P/E ratio of 41.20, whereas HDFCLIFE.NS's P/E ratio is 62.25. In terms of profitability, NIVABUPA.NS's ROE is +0.09%, compared to HDFCLIFE.NS's ROE of +0.11%. Regarding short-term risk, NIVABUPA.NS is less volatile compared to HDFCLIFE.NS. This indicates lower risk in terms of short-term price fluctuations for NIVABUPA.NS.Check HDFCLIFE.NS's competition here

Niva Bupa Health Insurance Company Limited (NSE: NIVABUPA.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVABUPA.NS stands at 147.2B. In comparison, ICICIPRULI.BO has a market cap of 715.9B. Regarding current trading prices, NIVABUPA.NS is priced at ₹79.59 on the NSE, while ICICIPRULI.BO trades at ₹493.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVABUPA.NS currently has a P/E ratio of 41.20, whereas ICICIPRULI.BO's P/E ratio is 42.35. In terms of profitability, NIVABUPA.NS's ROE is +0.09%, compared to ICICIPRULI.BO's ROE of +0.12%. Regarding short-term risk, NIVABUPA.NS is less volatile compared to ICICIPRULI.BO. This indicates lower risk in terms of short-term price fluctuations for NIVABUPA.NS.Check ICICIPRULI.BO's competition here

Niva Bupa Health Insurance Company Limited (NSE: NIVABUPA.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVABUPA.NS stands at 147.2B. In comparison, ICICIPRULI.NS has a market cap of 713.3B. Regarding current trading prices, NIVABUPA.NS is priced at ₹79.59 on the NSE, while ICICIPRULI.NS trades at ₹492.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVABUPA.NS currently has a P/E ratio of 41.20, whereas ICICIPRULI.NS's P/E ratio is 42.52. In terms of profitability, NIVABUPA.NS's ROE is +0.09%, compared to ICICIPRULI.NS's ROE of +0.12%. Regarding short-term risk, NIVABUPA.NS is less volatile compared to ICICIPRULI.NS. This indicates lower risk in terms of short-term price fluctuations for NIVABUPA.NS.Check ICICIPRULI.NS's competition here

Niva Bupa Health Insurance Company Limited (NSE: NIVABUPA.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVABUPA.NS stands at 147.2B. In comparison, MFSL.BO has a market cap of 548.8B. Regarding current trading prices, NIVABUPA.NS is priced at ₹79.59 on the NSE, while MFSL.BO trades at ₹1,575.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVABUPA.NS currently has a P/E ratio of 41.20, whereas MFSL.BO's P/E ratio is 290.06. In terms of profitability, NIVABUPA.NS's ROE is +0.09%, compared to MFSL.BO's ROE of +0.02%. Regarding short-term risk, NIVABUPA.NS is less volatile compared to MFSL.BO. This indicates lower risk in terms of short-term price fluctuations for NIVABUPA.NS.Check MFSL.BO's competition here

Niva Bupa Health Insurance Company Limited (NSE: NIVABUPA.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVABUPA.NS stands at 147.2B. In comparison, MFSL.NS has a market cap of 538B. Regarding current trading prices, NIVABUPA.NS is priced at ₹79.59 on the NSE, while MFSL.NS trades at ₹1,559.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVABUPA.NS currently has a P/E ratio of 41.20, whereas MFSL.NS's P/E ratio is 340.68. In terms of profitability, NIVABUPA.NS's ROE is +0.09%, compared to MFSL.NS's ROE of +0.02%. Regarding short-term risk, NIVABUPA.NS is less volatile compared to MFSL.NS. This indicates lower risk in terms of short-term price fluctuations for NIVABUPA.NS.Check MFSL.NS's competition here

Niva Bupa Health Insurance Company Limited (NSE: NIVABUPA.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVABUPA.NS stands at 147.2B. In comparison, STARHEALTH.BO has a market cap of 323.9B. Regarding current trading prices, NIVABUPA.NS is priced at ₹79.59 on the NSE, while STARHEALTH.BO trades at ₹546.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVABUPA.NS currently has a P/E ratio of 41.20, whereas STARHEALTH.BO's P/E ratio is 38.21. In terms of profitability, NIVABUPA.NS's ROE is +0.09%, compared to STARHEALTH.BO's ROE of +0.10%. Regarding short-term risk, NIVABUPA.NS is less volatile compared to STARHEALTH.BO. This indicates lower risk in terms of short-term price fluctuations for NIVABUPA.NS.Check STARHEALTH.BO's competition here

Niva Bupa Health Insurance Company Limited (NSE: NIVABUPA.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVABUPA.NS stands at 147.2B. In comparison, STARHEALTH.NS has a market cap of 321.9B. Regarding current trading prices, NIVABUPA.NS is priced at ₹79.59 on the NSE, while STARHEALTH.NS trades at ₹547.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVABUPA.NS currently has a P/E ratio of 41.20, whereas STARHEALTH.NS's P/E ratio is 38.28. In terms of profitability, NIVABUPA.NS's ROE is +0.09%, compared to STARHEALTH.NS's ROE of +0.10%. Regarding short-term risk, NIVABUPA.NS is less volatile compared to STARHEALTH.NS. This indicates lower risk in terms of short-term price fluctuations for NIVABUPA.NS.Check STARHEALTH.NS's competition here

Niva Bupa Health Insurance Company Limited (NSE: NIVABUPA.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVABUPA.NS stands at 147.2B. In comparison, CANHLIFE.BO has a market cap of 146.1B. Regarding current trading prices, NIVABUPA.NS is priced at ₹79.59 on the NSE, while CANHLIFE.BO trades at ₹153.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVABUPA.NS currently has a P/E ratio of 41.20, whereas CANHLIFE.BO's P/E ratio is 33.13. In terms of profitability, NIVABUPA.NS's ROE is +0.09%, compared to CANHLIFE.BO's ROE of N/A. Regarding short-term risk, NIVABUPA.NS is less volatile compared to CANHLIFE.BO. This indicates lower risk in terms of short-term price fluctuations for NIVABUPA.NS.Check CANHLIFE.BO's competition here